Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001095811-01-505225
Filing Date
2001-09-27
Accepted
2001-09-27 00:00:00
Documents
10
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K PERIOD ENDED JUNE 30, 2001 f75927ore10-k.txt 10-K 228258
3 EXHIBIT 10.14 f75927orex10-14.txt EX-10.14 5370
4 EXHIBIT 10.15 f75927orex10-15.txt EX-10.15 5654
5 EXHIBIT 10.32 f75927orex10-32.txt EX-10.32 18816
6 EXHIBIT 10.33 f75927orex10-33.txt EX-10.33 33204
7 EXHIBIT 10.34 f75927orex10-34.txt EX-10.34 23190
8 EXHIBIT 10.35 f75927orex10-35.txt EX-10.35 23160
9 EXHIBIT 10.37 f75927orex10-37.txt EX-10.37 23977
10 EXHIBIT 10.48 f75927orex10-48.txt EX-10.48 2889
11 EXHIBIT 23.1 f75927orex23-1.txt EX-23.1 836
  Complete submission text file 0001095811-01-505225.txt   367535
Mailing Address 1201 HARBOR BAY PARKWAY #1000 ALAMEDA CA 94502
Business Address 1201 HARBOR BAY PARKWAY SUITE 1000 ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

EIN.: 133647119 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-28272 | Film No.: 1746425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances